GlucoTrack (NASDAQ:GCTK) Downgraded by Wall Street Zen to Strong Sell

Wall Street Zen cut shares of GlucoTrack (NASDAQ:GCTK) to a strong sell rating in a report published on Saturday.

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of GlucoTrack in a research report on Tuesday, April 21st. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, GlucoTrack presently has a consensus rating of “Sell”.

GlucoTrack Stock Performance

Shares of GCTK stock opened at $0.49 on Friday. The company has a debt-to-equity ratio of 0.08, a current ratio of 0.85 and a quick ratio of 0.85. The company’s fifty day moving average price is $0.48 and its two-hundred day moving average price is $1.36. The firm has a market capitalization of $3.08 million, a P/E ratio of -0.03 and a beta of 0.77. GlucoTrack has a 12 month low of $0.29 and a 12 month high of $14.14.

Institutional Trading of GlucoTrack

A number of hedge funds have recently made changes to their positions in GCTK. Ikarian Capital LLC acquired a new stake in GlucoTrack in the fourth quarter valued at $177,000. Boothbay Fund Management LLC bought a new position in GlucoTrack during the 4th quarter valued at $52,000. Finally, Bank of America Corp DE grew its holdings in GlucoTrack by 102,125.0% during the 2nd quarter. Bank of America Corp DE now owns 4,089 shares of the company’s stock worth $25,000 after acquiring an additional 4,085 shares in the last quarter. Institutional investors and hedge funds own 10.92% of the company’s stock.

GlucoTrack Company Profile

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.